DE69525347D1 - Krebsbehandlung mittels humanen choriongonadotropin - Google Patents

Krebsbehandlung mittels humanen choriongonadotropin

Info

Publication number
DE69525347D1
DE69525347D1 DE69525347T DE69525347T DE69525347D1 DE 69525347 D1 DE69525347 D1 DE 69525347D1 DE 69525347 T DE69525347 T DE 69525347T DE 69525347 T DE69525347 T DE 69525347T DE 69525347 D1 DE69525347 D1 DE 69525347D1
Authority
DE
Germany
Prior art keywords
cancer treatment
choriongonadotropine
human
human choriongonadotropine
cancer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69525347T
Other languages
English (en)
Inventor
Yanto Lunardi-Iskandar
C Gallo
L Bryant
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
US Department of Health and Human Services
Original Assignee
US Department of Health and Human Services
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by US Department of Health and Human Services filed Critical US Department of Health and Human Services
Application granted granted Critical
Publication of DE69525347D1 publication Critical patent/DE69525347D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/24—Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69525347T 1994-08-05 1995-08-03 Krebsbehandlung mittels humanen choriongonadotropin Expired - Lifetime DE69525347D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/286,299 US5677275A (en) 1994-08-05 1994-08-05 Treatment of cancer with human chorionic gonadotropin
PCT/US1995/009892 WO1996004008A1 (en) 1994-08-05 1995-08-03 Treatment of cancer with human chorionic gonadotropin
AU53516/99A AU750123B2 (en) 1994-08-05 1999-10-07 Treatment of cancer with human chorionic gonadotropin

Publications (1)

Publication Number Publication Date
DE69525347D1 true DE69525347D1 (de) 2002-03-21

Family

ID=25630094

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69525347T Expired - Lifetime DE69525347D1 (de) 1994-08-05 1995-08-03 Krebsbehandlung mittels humanen choriongonadotropin

Country Status (7)

Country Link
US (2) US5677275A (de)
EP (1) EP0774973B1 (de)
JP (1) JPH10505588A (de)
AU (2) AU3238695A (de)
CA (1) CA2196748A1 (de)
DE (1) DE69525347D1 (de)
WO (1) WO1996004008A1 (de)

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin
DE69636814T2 (de) 1995-10-16 2007-10-04 Applied Research Systems Ars Holding N.V. Verwendung des menschlichen choriongonadotropins in der behandlung von kaposi's-sarcoma
US5968513A (en) * 1996-06-24 1999-10-19 University Of Maryland Biotechnology Institute Method of promoting hematopoiesis using derivatives of human chorionic gonadotropin
US5997871A (en) * 1996-06-24 1999-12-07 University Of Maryland Biotechnology Insitute Treatment and prevention of cancer by administration of derivatives of human chorionic gonadotropin
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
IT1284876B1 (it) * 1996-08-07 1998-05-22 Applied Research Systems Hcg come inibitore della collagenasi
US6331610B1 (en) 1997-04-25 2001-12-18 Metatron, Inc. Method for treating AIDS and HIV infection using select peptides from the beta subunit of human chorionic gonadotropin
US6583109B1 (en) 1997-06-24 2003-06-24 Robert C. Gallo Therapeutic polypeptides from β-hCG and derivatives
US6683050B1 (en) * 1997-08-01 2004-01-27 Altachem Pharma Ltd. Compounds with anti-KS and anti-HIV activity
CN1271365A (zh) * 1997-08-01 2000-10-25 阿尔塔切姆法尔马有限公司 具有抗－ks和抗hiv活性的化合物
US7175679B2 (en) * 2001-03-29 2007-02-13 Biotempt B.V. Oligopeptide treatment of NF-κB mediated inflammation
US6844315B2 (en) * 1998-05-20 2005-01-18 Erasmus Universiteit Rotterdam Immunoregulator
US20030220258A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of ischemic events
US8680059B2 (en) * 1998-05-20 2014-03-25 Biotempt B.V. Oligopeptide acetate and formulations thereof
US20050227925A1 (en) * 2004-04-08 2005-10-13 Robbert Benner Compositions capable of reducing elevated blood urea concentration
US6921751B1 (en) 1998-05-20 2005-07-26 Erasmus Universiteit Rotterdam Immunoregulator
EP1138692A1 (de) 2000-03-29 2001-10-04 Erasmus Universiteit Rotterdam Fragmente des menschlichen Choriongonadotropins als Immunoregulatoren
US20040202645A1 (en) * 2003-04-08 2004-10-14 Khan Nisar Ahmed Administration of gene-regulatory peptides
EP1013281A1 (de) * 1998-12-15 2000-06-28 Applied Research Systems ARS Holding N.V. hCG Therapie für Behandlung von Brustkrebs
US7994278B1 (en) 1999-08-06 2011-08-09 Nobel Biosciences Llc Biologically active polypeptides derived from a novel early stage pregnancy factor designated maternin (MA)
US6716428B1 (en) * 1999-10-06 2004-04-06 The Ohio State University Research Foundation Antigenic modification of polypeptides
US7358330B2 (en) 2001-03-29 2008-04-15 Biotempt B.V. Immunoregulatory compositions
USRE43279E1 (en) 2000-03-29 2012-03-27 Biotemp B.V. Compositions capable of reducing elevated blood urea concentration
EP1300418A1 (de) * 2001-10-04 2003-04-09 Erasmus Universiteit Rotterdam Genregulation durch Oligopeptide
US20050037430A1 (en) * 2000-03-29 2005-02-17 Biotempt B.V. Methods and uses for protein breakdown products
US7576174B2 (en) * 2000-03-29 2009-08-18 Biotempt B.V. Compositions capable of reducing elevated blood urea concentration
US20030220259A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of neurological disorders
US20030166147A1 (en) * 2001-12-14 2003-09-04 Lee Chichang Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
CA2470026A1 (en) * 2001-12-14 2003-06-26 Centocor, Inc. Clonal myeloma cell lines useful for manufacturing proteins in chemically defined media
US20030224995A1 (en) * 2001-12-21 2003-12-04 Khan Nisar Ahmed Treatment of burns
US20080242837A1 (en) * 2001-12-21 2008-10-02 Khan Nisar A Peptide compositions
US7501391B2 (en) * 2001-12-21 2009-03-10 Biotempt B.V. Treatment of transplant survival
US20030220261A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Treatment of iatrogenic disease
US20030220257A1 (en) * 2001-12-21 2003-11-27 Robbert Benner Treatment of trauma
US7786084B2 (en) * 2001-12-21 2010-08-31 Biotempt B.V. Treatment of burns
US7560433B2 (en) * 2001-12-21 2009-07-14 Biotempt B.V. Treatment of multiple sclerosis (MS)
US20080318871A1 (en) * 2001-12-21 2008-12-25 Khan Nisar A Treatment of neurological disorders
US20040013661A1 (en) * 2001-12-21 2004-01-22 Gert Wensvoort Stratification
US20030220260A1 (en) * 2001-12-21 2003-11-27 Khan Nisar Ahmed Peptide compositions
US7517529B2 (en) * 2003-04-08 2009-04-14 Biotempt B.V. Treatment of type I diabetes
US20090227505A1 (en) * 2004-01-07 2009-09-10 Biotempt B.V. Methods and uses for protein breakdown products
CA2614084A1 (en) * 2005-07-05 2007-01-11 Biotempt B.V. Treatment of tumors
US20080139457A1 (en) * 2005-09-16 2008-06-12 Virginia Commonwealth University Therapeutic compositions comprising chorionic gonadotropins and HMG CoA reductase inhibitors
EP1864692A1 (de) * 2006-06-07 2007-12-12 Biotempt B.V. Verwendung von peptiden zum Schutz von Strahlenschäden
PT2120991E (pt) * 2007-02-12 2014-05-02 Biotempt Bv Tratamento d a hemorragia traumática com oligopéptidos curtos
WO2009033724A1 (en) * 2007-09-11 2009-03-19 Mondobiotech Laboratories Ag Use of c-type natriuretic peptide, alone or incombination with neuropeptide af, as a therapeutic agent
RU2010114002A (ru) * 2007-09-11 2011-10-20 Мондобайотек Лабораториз Аг (Li) Применение фактора ингибирования высвобождения меланотропина в качестве терапевтического средства при лечении инфекции pseudomonas aeruginosa
EP2109054A1 (de) * 2008-04-09 2009-10-14 Biotempt B.V. Verfahren zur Identifizierung biologisch aktiver Peptide und Vorhersage ihrer Funktion
EP2490021A1 (de) 2011-02-18 2012-08-22 Biotempt B.V. Modulatoren von PRR- und GPCR-Signalisierung
US8680086B2 (en) 2011-04-15 2014-03-25 Neuralight Hd, Llc Methods for chronic pain management and treatment using HCG
US20120265129A1 (en) 2011-04-15 2012-10-18 Neuralight Hd, Llc Methods for Chronic Pain Management and Treatment using HCG
US20150290292A1 (en) 2012-10-18 2015-10-15 Neuralight Hd, Llc Treatment of Depression and PTSD

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4692332A (en) * 1985-01-18 1987-09-08 Mcmichael John Immunotherapeutic methods and compositions employing antigens characteristic of malignant neoplasms
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
GB9010058D0 (en) * 1990-05-04 1990-06-27 Health Lab Service Board Method and composition for the treatment of cancer
WO1994020859A1 (fr) * 1993-03-11 1994-09-15 Laboratoire L. Lafon TROUSSE DE DIAGNOSTIC D'UN CANCER SECRETANT L'hCG OU DES FRAGMENTS D'hCG ET MOYENS DESTINES A L'IMMUNOTHERAPIE D'UN TEL CANCER
US5677275A (en) * 1994-08-05 1997-10-14 The United States Of America As Represented By The Department Of Health And Human Services Treatment of cancer with human chorionic gonadotropin

Also Published As

Publication number Publication date
AU750123B2 (en) 2002-07-11
US5677275A (en) 1997-10-14
WO1996004008A1 (en) 1996-02-15
CA2196748A1 (en) 1996-02-15
AU5351699A (en) 2000-06-08
US5877148A (en) 1999-03-02
EP0774973B1 (de) 2002-02-06
EP0774973A1 (de) 1997-05-28
JPH10505588A (ja) 1998-06-02
AU3238695A (en) 1996-03-04

Similar Documents

Publication Publication Date Title
DE69525347D1 (de) Krebsbehandlung mittels humanen choriongonadotropin
DE69524138D1 (de) Hautbehandlungsmittel
DE69522448D1 (de) Gewebebehandlungskassette
DK0521501T3 (da) Elektrokirurgisk behandlingsinstrument
DE69623722D1 (de) Blutbehandlungsgerät
DE69618188D1 (de) Kosmetisches hautbehandlungsverfahren
ATE307601T1 (de) Brustkrebsbehandlung mittels natürlicher ätherischer öle
FR2777466B1 (fr) Appareil de traitement de tumeur
BR9101494A (pt) Tratamento de tecidos
ID23528A (id) Pengobatan terapeutik untuk gangguan kulit
DE69528637D1 (de) Hautbehandlungsmittel gegen akne
NO953349L (no) Kombinasjonsterapi av human cancer med cisplatin/tamoxifen
DE69614890D1 (de) Hautstreckmaschine
DE59607418D1 (de) Haarbehandlungsmittel
DE9407101U1 (de) Thermisches Hautbehandlungsgerät
ATE212858T1 (de) Krebsbehandlung mittels humanen choriongonadotropin
DE9419787U1 (de) Bestrahlungsliege
DE29612101U1 (de) Behandlungsliege
DE9418730U1 (de) Patientenliege
DE29723443U1 (de) Behandlungsliege
DE9418331U1 (de) Behandlungsliege
DE29513387U1 (de) Behandlungsliege
DE9312888U1 (de) Hautbestrahlungsgerät
DE29516192U1 (de) Behandlungsliege
KR920000326U (ko) 두피 마사지기

Legal Events

Date Code Title Description
8332 No legal effect for de